PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL

Detalhes bibliográficos
Autor(a) principal: Jennifer Naed Martins de Freitas
Data de Publicação: 2023
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFMS
Texto Completo: https://repositorio.ufms.br/handle/123456789/6976
Resumo: Oropharyngeal cancer has increased among young people and adults in recent years and has as one of the main causes the human papillomavirus (HPV) infection, which is considered a sexually transmitted infection (STI). Leukoplakia is the most common potentially neoplastic lesion in the oral cavity, with a high risk for developing oral squamous cell cancer. The lesions in the oral cavity have risk factors in common, and there is the possibility that human papillomavirus (HPV) infection may favor malignant transformation in different leukoplastic lesions, thus progressing to oral squamous cell carcinoma (OSCC). The immune system is responsible for eliminating HPV in most infections, however the persistence of the virus is a predisposing factor for malignant transformation of infected cells. NK cells are responsible for eliminating virus-infected cells and tumor cells. Macrophages can be activated by the classical route, where they are called M1 and destroy microorganisms, triggering inflammation, or by the alternative route, being called M2 or tumor-associated macrophages (TAM). The present work aimed to correlate the expression of CD57 (Natural Killer - NK cells) and CD163 (M2 macrophages) to the detection of HPV DNA in patients with leukoplakia and CEO. The participants were selected in the period from 2018 to 2020 in the Clinics of the School of Dentistry of UFMS and the Center for Dental Specialties of the Municipal Health Secretariat of Campo Grande - MS. CEP/UFMS 2.621.049. For HPV detection by Nested PCR, exfoliated cells obtained from the surface of the lesions were collected and after this collection, patients underwent surgical procedures for biopsy of the lesions, used for histopathology and immunohistochemistry. The frequency of HPV DNA detection among the research participants was 27.78% (10/36). Lesions were classified as Epithelium Without Dysplasia (n=6), Discrete Epithelial Dysplasia (n=7), Moderate Epithelial Dysplasia (n=9) and CEO (n=17). In specimens histologically classified as CEO, the expression of CD163 (M2 macrophages) was higher (4456.32 cels/mm3), whereas the expression of CD57 (NK cells) was lower (2741.05 cels/mm3). There was no relationship between positivity for HPV DNA and the expression of CD163 and CD57 (p>0.05). There was no relationship between HPV DNA positivity and histopathological findings. High expression of CD163 and lower expression of CD57 in tissues with CEO represents a worse prognosis considering the pro-tumor activity of M2 macrophages and lower amount of NK cells that could eliminate tumor cells containing tumor progression. Keywords: Oral Cavity, Epithelial Dysplasia, Immunohistochemistry.
id UFMS_a93b4520f8bf1d0fde1f322aa81b5962
oai_identifier_str oai:repositorio.ufms.br:123456789/6976
network_acronym_str UFMS
network_name_str Repositório Institucional da UFMS
repository_id_str 2124
spelling 2023-11-22T19:12:22Z2023-11-22T19:12:22Z2023https://repositorio.ufms.br/handle/123456789/6976Oropharyngeal cancer has increased among young people and adults in recent years and has as one of the main causes the human papillomavirus (HPV) infection, which is considered a sexually transmitted infection (STI). Leukoplakia is the most common potentially neoplastic lesion in the oral cavity, with a high risk for developing oral squamous cell cancer. The lesions in the oral cavity have risk factors in common, and there is the possibility that human papillomavirus (HPV) infection may favor malignant transformation in different leukoplastic lesions, thus progressing to oral squamous cell carcinoma (OSCC). The immune system is responsible for eliminating HPV in most infections, however the persistence of the virus is a predisposing factor for malignant transformation of infected cells. NK cells are responsible for eliminating virus-infected cells and tumor cells. Macrophages can be activated by the classical route, where they are called M1 and destroy microorganisms, triggering inflammation, or by the alternative route, being called M2 or tumor-associated macrophages (TAM). The present work aimed to correlate the expression of CD57 (Natural Killer - NK cells) and CD163 (M2 macrophages) to the detection of HPV DNA in patients with leukoplakia and CEO. The participants were selected in the period from 2018 to 2020 in the Clinics of the School of Dentistry of UFMS and the Center for Dental Specialties of the Municipal Health Secretariat of Campo Grande - MS. CEP/UFMS 2.621.049. For HPV detection by Nested PCR, exfoliated cells obtained from the surface of the lesions were collected and after this collection, patients underwent surgical procedures for biopsy of the lesions, used for histopathology and immunohistochemistry. The frequency of HPV DNA detection among the research participants was 27.78% (10/36). Lesions were classified as Epithelium Without Dysplasia (n=6), Discrete Epithelial Dysplasia (n=7), Moderate Epithelial Dysplasia (n=9) and CEO (n=17). In specimens histologically classified as CEO, the expression of CD163 (M2 macrophages) was higher (4456.32 cels/mm3), whereas the expression of CD57 (NK cells) was lower (2741.05 cels/mm3). There was no relationship between positivity for HPV DNA and the expression of CD163 and CD57 (p>0.05). There was no relationship between HPV DNA positivity and histopathological findings. High expression of CD163 and lower expression of CD57 in tissues with CEO represents a worse prognosis considering the pro-tumor activity of M2 macrophages and lower amount of NK cells that could eliminate tumor cells containing tumor progression. Keywords: Oral Cavity, Epithelial Dysplasia, Immunohistochemistry.O câncer orofaríngeo tem aumentado entre jovens e adultos nos últimos anos e tem como uma das principais causas a infecção por Papilomavírus humano (HPV), que é considerada uma Infecção sexualmente transmissível (IST). A leucoplasia é a lesão potencialmente neoplásica mais comum na cavidade oral apresentando grande risco para desenvolvimento de câncer epidermoide oral. As lesões na cavidade oral têm fatores de risco em comum, existindo a possibilidade de que a infecção por Papilomavírus humano (HPV) possa favorecer a transformação maligna nas diferentes lesões leucoplásicas e assim, progredindo para carcinoma epidermoide oral (CEO). O sistema imune é responsável pela eliminação do HPV na maioria das infecções, entretanto a persistência do vírus é fator predisponente para a transformação maligna das células infectadas. As células NK são responsáveis por eliminar células infectadas por vírus e células tumorais. Já os macrófagos podem ser ativados pela via clássica, onde são chamados de M1 e destroem microrganismos, desencadeiam a inflamação, ou pela via alternativa sendo denominados M2 ou macrófagos associados a tumor (TAM). O presente trabalho visou correlacionar a expressão de CD57 (células Natural Killer - NK) e CD163 (Macrófagos M2) à detecção de DNA de HPV em pacientes com leucoplasia e CEO. Os participantes foram selecionados no período de 2018 a 2020 nas Clínicas da Faculdade de Odontologia da UFMS e no Centro de Especialidades Odontológicas da Secretaria Municipal de Saúde de Campo Grande - MS. CEP/UFMS 2.621.049. Para a detecção do HPV por Nested PCR, foram coletadas células esfoliadas obtidas da superfície das lesões e após esta coleta, os pacientes foram submetidos a procedimentos cirúrgicos para biópsia das lesões, utilizadas para histopatologia e imunohistoquímica. A frequência de detecção do DNA de HPV entre os participantes da pesquisa foi de 27,78% (10/36). As lesões foram classificadas como Epitélio Sem Displasia (n=6), Displasia Epitelial Discreta (n=7), Displasia Epitelial Moderada (n=9) e CEO (n=17). Em amostras classificadas histologicamente como CEO, a expressão de CD163 (macrófagos M2) foi maior (4456,32 cels/mm3 ), enquanto que a expressão de CD57 (células NK) foi menor (2741,05 cels/mm3 ). Não houve relação entre a positividade para DNA de HPV e a expressão de CD163 e CD57 (p>0,05). Não houve relação entre a positividade para DNA de HPV e os resultados histopatológicos. Elevada expressão de CD163 e menor expressão de CD57 em tecidos com CEO representa um pior prognóstico considerando a atividade pró- tumoral dos macrófagos M2 e menor quantidade de células NK que poderiam eliminar as células tumorais contendo a progressão do tumor. Palavras-chave: Cavidade Oral, Displasia epitelial e Imunohistoquímica.Fundação Universidade Federal de Mato Grosso do SulUFMSBrasilCavidade Oral, Displasia epitelial e Imunohistoquímica.PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORALinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisInes Aparecida TozettiJennifer Naed Martins de Freitasinfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMSinstname:Universidade Federal de Mato Grosso do Sul (UFMS)instacron:UFMSORIGINALdissertação Jennifer Naed. entrega para a pós.pdfdissertação Jennifer Naed. entrega para a pós.pdfapplication/pdf2401734https://repositorio.ufms.br/bitstream/123456789/6976/-1/disserta%c3%a7%c3%a3o%20Jennifer%20Naed.%20entrega%20para%20a%20p%c3%b3s.pdfa7291885509d6ec72557772c6140bfddMD5-1123456789/69762023-11-22 15:12:30.074oai:repositorio.ufms.br:123456789/6976Repositório InstitucionalPUBhttps://repositorio.ufms.br/oai/requestri.prograd@ufms.bropendoar:21242023-11-22T19:12:30Repositório Institucional da UFMS - Universidade Federal de Mato Grosso do Sul (UFMS)false
dc.title.pt_BR.fl_str_mv PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
title PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
spellingShingle PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
Jennifer Naed Martins de Freitas
Cavidade Oral, Displasia epitelial e Imunohistoquímica.
title_short PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
title_full PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
title_fullStr PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
title_full_unstemmed PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
title_sort PRESENÇA DE CÉLULAS CD57+, CD163+ E DNA PAPILOMAVÍRUS HUMANO NA CAVIDADE ORAL DE PACIENTES COM LEUCOPLASIA E CARCINOMA EPIDERMOIDE ORAL
author Jennifer Naed Martins de Freitas
author_facet Jennifer Naed Martins de Freitas
author_role author
dc.contributor.advisor1.fl_str_mv Ines Aparecida Tozetti
dc.contributor.author.fl_str_mv Jennifer Naed Martins de Freitas
contributor_str_mv Ines Aparecida Tozetti
dc.subject.por.fl_str_mv Cavidade Oral, Displasia epitelial e Imunohistoquímica.
topic Cavidade Oral, Displasia epitelial e Imunohistoquímica.
description Oropharyngeal cancer has increased among young people and adults in recent years and has as one of the main causes the human papillomavirus (HPV) infection, which is considered a sexually transmitted infection (STI). Leukoplakia is the most common potentially neoplastic lesion in the oral cavity, with a high risk for developing oral squamous cell cancer. The lesions in the oral cavity have risk factors in common, and there is the possibility that human papillomavirus (HPV) infection may favor malignant transformation in different leukoplastic lesions, thus progressing to oral squamous cell carcinoma (OSCC). The immune system is responsible for eliminating HPV in most infections, however the persistence of the virus is a predisposing factor for malignant transformation of infected cells. NK cells are responsible for eliminating virus-infected cells and tumor cells. Macrophages can be activated by the classical route, where they are called M1 and destroy microorganisms, triggering inflammation, or by the alternative route, being called M2 or tumor-associated macrophages (TAM). The present work aimed to correlate the expression of CD57 (Natural Killer - NK cells) and CD163 (M2 macrophages) to the detection of HPV DNA in patients with leukoplakia and CEO. The participants were selected in the period from 2018 to 2020 in the Clinics of the School of Dentistry of UFMS and the Center for Dental Specialties of the Municipal Health Secretariat of Campo Grande - MS. CEP/UFMS 2.621.049. For HPV detection by Nested PCR, exfoliated cells obtained from the surface of the lesions were collected and after this collection, patients underwent surgical procedures for biopsy of the lesions, used for histopathology and immunohistochemistry. The frequency of HPV DNA detection among the research participants was 27.78% (10/36). Lesions were classified as Epithelium Without Dysplasia (n=6), Discrete Epithelial Dysplasia (n=7), Moderate Epithelial Dysplasia (n=9) and CEO (n=17). In specimens histologically classified as CEO, the expression of CD163 (M2 macrophages) was higher (4456.32 cels/mm3), whereas the expression of CD57 (NK cells) was lower (2741.05 cels/mm3). There was no relationship between positivity for HPV DNA and the expression of CD163 and CD57 (p>0.05). There was no relationship between HPV DNA positivity and histopathological findings. High expression of CD163 and lower expression of CD57 in tissues with CEO represents a worse prognosis considering the pro-tumor activity of M2 macrophages and lower amount of NK cells that could eliminate tumor cells containing tumor progression. Keywords: Oral Cavity, Epithelial Dysplasia, Immunohistochemistry.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-11-22T19:12:22Z
dc.date.available.fl_str_mv 2023-11-22T19:12:22Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.ufms.br/handle/123456789/6976
url https://repositorio.ufms.br/handle/123456789/6976
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fundação Universidade Federal de Mato Grosso do Sul
dc.publisher.initials.fl_str_mv UFMS
dc.publisher.country.fl_str_mv Brasil
publisher.none.fl_str_mv Fundação Universidade Federal de Mato Grosso do Sul
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMS
instname:Universidade Federal de Mato Grosso do Sul (UFMS)
instacron:UFMS
instname_str Universidade Federal de Mato Grosso do Sul (UFMS)
instacron_str UFMS
institution UFMS
reponame_str Repositório Institucional da UFMS
collection Repositório Institucional da UFMS
bitstream.url.fl_str_mv https://repositorio.ufms.br/bitstream/123456789/6976/-1/disserta%c3%a7%c3%a3o%20Jennifer%20Naed.%20entrega%20para%20a%20p%c3%b3s.pdf
bitstream.checksum.fl_str_mv a7291885509d6ec72557772c6140bfdd
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional da UFMS - Universidade Federal de Mato Grosso do Sul (UFMS)
repository.mail.fl_str_mv ri.prograd@ufms.br
_version_ 1807552812131811328